Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
1996 |
Griffith DE, Brown BA, Girard WM, Murphy DT, Wallace RJ. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 23: 983-9. PMID 8922790 DOI: 10.1093/CLINIDS/23.5.983 |
0.261 |
|
1994 |
Wallace RJ, Brown BA, Griffith DE, Girard WM, Murphy DT, Onyi GO, Steingrube VA, Mazurek GH. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. American Journal of Respiratory and Critical Care Medicine. 149: 1335-41. PMID 8173775 DOI: 10.1164/ajrccm.149.5.8173775 |
0.234 |
|
2002 |
Wallace Jr RJ, Zhang Y, Brown-Elliott BA, Yakrus MA, Wilson RW, Mann L, Couch L, Girard WM, Griffith DE. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis. The Journal of Infectious Diseases. 186: 266-73. PMID 12134265 DOI: 10.1086/341207 |
0.225 |
|
1992 |
Dismukes WE, Bradsher RW, Cloud GC, Kauffman CA, Chapman SW, George RB, Stevens DA, Girard WM, Saag MS, Bowles-Patton C. Itraconazole therapy for blastomycosis and histoplasmosis The American Journal of Medicine. 93: 489-497. PMID 1332471 DOI: 10.1016/0002-9343(92)90575-V |
0.221 |
|
1995 |
Griffith DE, Brown BA, Girard WM, Wallace RJ. Adverse events associated with high-dose rifabutin in macrolide-containing regimens for the treatment of Mycobacterium avium complex lung disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 21: 594-8. PMID 8527549 DOI: 10.1093/clinids/21.3.594 |
0.219 |
|
1996 |
Wallace RJ, Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. American Journal of Respiratory and Critical Care Medicine. 153: 1766-72. PMID 8665032 DOI: 10.1164/ajrccm.153.6.8665032 |
0.218 |
|
1998 |
Griffith DE, Brown BA, Murphy DT, Girard WM, Couch L, Wallace RJ. Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients. The Journal of Infectious Diseases. 178: 121-6. PMID 9652431 DOI: 10.1086/515597 |
0.216 |
|
1993 |
Griffith DE, Girard WM, Wallace RJ. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. The American Review of Respiratory Disease. 147: 1271-8. PMID 8484642 DOI: 10.1164/ajrccm/147.5.1271 |
0.212 |
|
2001 |
Griffith DE, Brown BA, Girard WM, Griffith BE, Couch LA, Wallace Jr RJ. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 32: 1547-53. PMID 11340525 DOI: 10.1086/320512 |
0.209 |
|
1996 |
McKinsey DS, Kauffman CA, Pappas PG, Cloud GA, Girard WM, Sharkey PK, Hamill RJ, Thomas CJ, Dismukes WE. Fluconazole therapy for histoplasmosis Clinical Infectious Diseases. 23: 996-1001. PMID 8922792 DOI: 10.1093/CLINIDS/23.5.996 |
0.197 |
|
1979 |
Jenkinson SG, George RB, Light RW, Girard WM. Cefazolin vs Penicillin: Treatment of Uncomplicated Pneumococcal Pneumonia Jama: the Journal of the American Medical Association. 241: 2815-2817. PMID 448844 DOI: 10.1001/jama.1979.03290520039024 |
0.176 |
|
1996 |
Frothingham R, Wallace RJ, Griffith DE, Brown BA, Girard WM. Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease [2] American Journal of Respiratory and Critical Care Medicine. 153: 1990-1991. PMID 8665069 |
0.158 |
|
1996 |
Wallace RJ, Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary mycobacterium avium complex - The first 50 patients Pneumologie. 50: 732. |
0.142 |
|
2006 |
Griffith DE, Brown-Elliott BA, Langsjoen B, Zhang Y, Pan X, Girard W, Nelson K, Caccitolo J, Alvarez J, Shepherd S, Wilson R, Graviss EA, Wallace RJ. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. American Journal of Respiratory and Critical Care Medicine. 174: 928-34. PMID 16858014 DOI: 10.1164/rccm.200603-450OC |
0.127 |
|
1980 |
Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions The American Journal of Medicine. 69: 507-512. PMID 7424940 DOI: 10.1016/0002-9343(80)90460-X |
0.124 |
|
2013 |
Girard W. The outpouring of development: place, prosperity, and the Holy Spirit in Zion Ministries Religion. 43: 385-402. DOI: 10.1080/0048721X.2013.798169 |
0.105 |
|
2008 |
Garg A, Barnes PF, Porgador A, Roy S, Wu S, Nanda JS, Griffith DE, Girard WM, Rawal N, Shetty S, Vankayalapati R. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor (Journal of Immunology (2006) 177, (6192-6198)) Journal of Immunology. 181: 8797. |
0.099 |
|
1995 |
McLarty JW, Holiday DB, Girard WM, Yanagihara RH, Kummet TD, Greenberg SD. β-Carotene, vitamin A, and lung cancer chemoprevention: Results of an intermediate endpoint study American Journal of Clinical Nutrition. 62. PMID 7495244 |
0.097 |
|
2001 |
Vankayalapati R, Wizel B, Samten B, Griffith DE, Shams H, Galland MR, Von Reyn CF, Girard WM, Wallace RJ, Barnes PF. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. The Journal of Infectious Diseases. 183: 478-84. PMID 11133380 DOI: 10.1086/318087 |
0.09 |
|
1976 |
Girard WM, Ahn CH, Light RW, Cush R, George RB. Epidemiology of atypical mycobacterial disease in Texas and Louisiana Bulletin of the International Union Against Tuberculosis. 51: 263-266. PMID 1030294 |
0.089 |
|
1986 |
Kronenberg RS, Girard WM. Sleep disordered breathing in chronic obstructive pulmonary disease Seminars in Respiratory Medicine. 8: 171-176. |
0.087 |
|
1977 |
Girard WM, Light RW, George RB. Treatment of pneumococcal pneumonia: a comparison of penicillin and cefazolin Clinical Research. 25. |
0.079 |
|
2005 |
Vankayalapati R, Garg A, Porgador A, Griffith DE, Klucar P, Safi H, Girard WM, Cosman D, Spies T, Barnes PF. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. Journal of Immunology (Baltimore, Md. : 1950). 175: 4611-7. PMID 16177106 |
0.078 |
|
2006 |
Garg A, Barnes PF, Porgador A, Roy S, Wu S, Nanda JS, Griffith DE, Girard WM, Rawal N, Shetty S, Vankayalapati R. Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor. Journal of Immunology (Baltimore, Md. : 1950). 177: 6192-8. PMID 17056548 |
0.075 |
|
2000 |
Vankayalapati R, Wizel B, Weis SE, Samten B, Girard WM, Barnes PF. Production of interleukin-18 in human tuberculosis. The Journal of Infectious Diseases. 182: 234-9. PMID 10882602 DOI: 10.1086/315656 |
0.054 |
|
1983 |
Girard WM, Light RW. Should the FVC be considered in evaluating response to bronchodilator? Chest. 84: 87-89. PMID 6861550 |
0.019 |
|
Hide low-probability matches. |